Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
Vladan VucinicMadlen JentzschSabine LeibleinEnrica BachYvonne RemaneKai Schulze-ForsterMichael CrossWolfram PönischSebastian SchwindGeorg-Nikolaus FrankeUwe PlatzbeckerDietger NiederwieserPublished in: Transfusion (2021)
The results of this trial showed that stem cell mobilization with pegfilgrastim is a feasible, and attractive option. This is the first trial presenting the kinetics of pegfilgrastim serum levels in healthy donors.